One new, namely 6-methoxykaempferol 3-O-[β-apiofuranosyl(1→2)]-β-glucopyranosyl(1→6)-β-glucopyranoside (2), and two known flavonoid glycosides, spinacetin 3-O-[β-apiofuranosyl(1→2)]-β-glucopyranosyl(1→6)-β-glucopyranoside (1) and spinacetin 3-O-gentiobioside (3), were isolated from the roots of Chenopodium bonus-henricus L. Their structures were determined by means of spectroscopic methods (1D, 2D NMR, UV, IR) and HR-ESI-MS. Radical scavenging and anti-oxidant activities of 1 and 3 were established using DPPH and ABTS free radicals, FRAP assay and inhibition of lipid peroxidation (LP) in a linoleic acid system by the ferric thiocyanate method. Compound 3 was found to possess stronger DPPH and ABTS radical scavenging activity (IC 50 0.44 ± 0.008 mM and 0.089 ± 0.002 mM, respectively) compared with 1 (IC 50 1.22 ± 0.010 mM and 0.11 ± 0.004 mM, respectively). Both flavonoids inhibited the lipid peroxidation of linoleic acid significantly. Additionally, 1 and 3 significantly reduced the cellular damage caused by the hepatotoxic agent CCl 4 in rat hepatocytes and preserved cell viability and GSH level, decreased LDH leakage and reduced lipid damage. Effects were similar to those of the positive control silymarin. Control of self-toxic effects made in a MTT based assay using HepG2 cells revealed statistically significant cytotoxic effects only in very high concentrations (exceeding mM) and an incubation time of 72 h, making flavonoid glycosides with a 6-methoxykaempferol skeleton a promising and safe class of hepatoprotective compounds.
The powdered roots of C. bonus-henricus L were extracted with MeOH, aq. MeOH and H 2 O. The resulting extracts were combined and subjected to CC on Diaion HP20 and MCI-gel resins. Semipreparative HPLC was employed as a final purification step that led to the isolation of compounds 1-3. The major flavonoid components 1 and 3 were identified as spinacetin 3-O-β-glucopyranosyl(1→6)-[β-apiofuranosyl(1→2)]-β-glucopyranoside and spinacetin 3-O-βgentiobioside ( Figure 1) , respectively, by comparison with literature data [4] .
The new compound 2 was isolated as a yellow powder and gave a pseudomolecular ion peak at m/z 773. 2135 [M+H] + in the positiveion HR-ESI-MS, consistent with the molecular formula C 33 H 41 O 21 . The IR spectrum showed absorption bands for hydroxyl groups (3292 cm -1 ), conjugated carbonyl (1652 cm -1 ) and unsaturated double bonds (1608, 1563 cm -1 ). Its UV spectrum exhibited the characteristic bands of a C-3 substituted flavonol derivative, as indicated by the bathochromic shift after addition of diagnostic reagents [5] . The signals in the 1 H-and 13 C-spectra (Table 1) of 2 were unambiguously assigned using 2D NMR techniques, i.e. COSY, HSQC and HMBC. Multiplicities were determined using 1 H-and HSQC spectra. The 1 H NMR spectrum was typical of a flavonoid with a tri-substituted A-ring showing only one singlet at δ H 6.50. A broad singlet at δ H 12.75 was due to OH-5 proton involved in hydrogen bonding. The presence of two AA′BB′-type proton signals at δ H 6.87 (2H, J = 8.9 Hz) and 8.04 (2H, J = 8.9 Hz) showed that position 4' of the B-ring was oxygenated. The threeproton singlet at δ H 3.75 showed correlation with C-6 (δ C 131.2) in the HMBC experiment and was attributed to the methoxyl group at position 6. In the 1 H NMR spectrum three anomeric proton doublets NPC Natural Product Communications 2015 Vol. 10 No. 8 1377 -1380 
3.45, m; 3.39, m 64.3, CH 2 a Chemical shifts were referenced to the solvent signals (residual DMSO-d 6 at δ H 2.50 for protons and δ C 39.51 for carbons). b Signals overlapped. appeared at δ H 5.50 (J = 7.5 Hz), 3.87 (J = 7.8 Hz) and 5.34 (J = 1.0 Hz) indicating the presence of three sugar units. The most downfield resonating doublet exhibited a cross-peak with the signal for C-3 (δ C 132.6) showing clearly the position of glycosidation. The 1 H-, 13 C-NMR and 2D NMR confirmed the presence of the gentiobiosyl-substituent at OH-3 [6] substituted with an apionosyl moiety. The gentiobiose-type linkage of the sugar moiety was confirmed by HMBC showing correlations between methylene protons (H-6'') of the inner glucose (δ H 3.81 and 3.38) and the anomeric carbon (C-1''') of the terminal sugar (δ C 103.2). In addition, the anomeric proton (H-1''') of the terminal glucose (δ H 3.87) correlated with the methylene carbon (C-6'') of the inner sugar (δ C 67.9). An anomeric proton signal at δ H 5.34 (J = 1 Hz) in the 1 H NMR spectrum gave a HMBC correlation with C-2'' (δ C 76.9) of the inner glucopyranosyl moiety. The cross-peak between the proton signal of H-2'' (δ H 3.43) of the inner glucose and the anomeric carbon C-1'''' (δ C 108.7) of apiose was also observed. Accordingly, the sugar signals in the 13 C NMR spectrum were typical for triglycosides with primary β-D-glucopyranose glycosidated at C-2'' (δ C shifted to downfield 76.9) and C-6'' (downfield shifted to δ C 67.9) with β-apiofuranose and β-glucopyranose [6] . The presence of D-glucose and D-apiose was authenticated by acid hydrolysis and synthesis of their tolylthiocarbamoyl-thiazolidine derivatives [7] . Consequently, the new compound 2 was identified as 6- Figure 1 ).
Anti-oxidant tests:
Radical scavenging and antioxidant activities of 1 and 3 were established using DPPH and ABTS free radicals, FRAP assay, and inhibition of lipid peroxidation (LP) in a linoleic acid system by the ferric thiocyanate method. Compound 3 was found to possess stronger DPPH and ABTS radical scavenging activity (IC 50 0.44 ± 0.008 mM and 0.09 ± 0.002 mM, respectively) compared with compound 1 (IC 50 1.22 ± 0.010 mM and 0.11 ± 0.004 mM, respectively) ( Table 2 ). Results are represented as means±standard deviation, n=3.
The flavonoids 1 and 3 also significantly inhibited the lipid peroxidation of linoleic acid (Table 3 ). Effects on isolated hepatocytes: Incubation of rat hepatocytes with CCl 4 (86 µМ) resulted in a statistically significant reduction of cell viability by 76%, increased LDH leakage by 210%, depletion of cell GSH by 77% and increased MDA level by 244%, compared with the control.
Pre-administration of 100 µM of the flavonoids 1 and 3 significantly reduced the cell damage caused by the hepatotoxic agent CCl 4 . Cell viability and GSH level were preserved and LDH leakage as well as lipid damage were reduced compared with CCl 4 alone ( Table 4 ). The effects were in the same range as those of the clinically approved hepatoprotective flavonoid complex silymarin from Silybum marianum (L.) Gaertn., which served as a positive control. Compounds 1 and 3 showed very similar pharmacological effects in the hepatocytes and roughly increased cell viability threefold. GSH levels were more than doubled from 5 ± 0.5 nM/mill cells after addition of CCl 4 to 11 ± 1.4 and 12 ± 1.4 nM/mill cells, respectively, when adding the flavonoid glycosides 1 and 3. LDH leakage and MDA level were reduced to approximately 50%, compared with the effect of the toxic agent alone (Table 4 ). 
Effects of 1 and 3 on HepG2 cell line:
In order to measure selftoxic effects of the flavonoids both compounds were tested against a HepG2 cell line. For the HepG2 cell line, some of the markers for cytotoxicity of biologically active compounds are cell viability and increased leakage of the enzyme lactate dehydrogenase (LDH) into the medium.
After 24 h incubation 1 decreased cell viability by 23% at 1.25 mM up to 71% at 5 mM. Results obtained for 3 were nearly identical (21% to 71% at 1.5 and 6 mM, respectively). Longer incubations of 48 and 72 h led to very similar results for both compounds (Table  5 ). A 0.1 mM concentration, as used in the heptoprotective assay, showed no cytotoxic effects ( Table 5 ).
In the LDH assay neither flavonoid significantly changed LDH leakage after 24 h at 1.25 and 1.5 mM. Higher concentrations (2.5 to 6.0 mM) and longer incubation times (48 and 72 h) led to an increased LDH leakage up to 51% and 60% for 3 and 1, respectively ( Table 5 ).
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Significance levels: a p < 0.001 vs control, b p < 0.01, n=3. "-"did not decrease cell viability and did not increase LDH leakage.
Isolated liver cells have been used as a suitable model for evaluation of cytoprotective compounds. It is well known that CCl 4 is bio-activated by CYP2E1, as well as by CYP2B1 and possibly CYP3A, to form the trichlormethyl radical (•CCl 3 ), which initiates the chain reaction of lipid peroxidation [8] . Pre-incubation of the hepatocytes with 1 and 3 significantly protected them against carbon tetrachloride toxicity. The effects are similar to those of the silymarin complex, a proven hepatoprotective flavanonol mixture with anti-oxidant activity. It is known that silibinin (the best investigated compound in the silymarin complex) inactivates human CYP3A4 and CYP2C9, as well as the main liver glucuronosyltransferases [9] . In isolated rat hepatocytes and with CCl 4 as toxic agent, hepatoprotective effects of silymarin and compounds 1 and 3 are possibly connected to a change in the activity of some isoforms of cytochrome P450, playing a role in carbon tetrachloride-induced bioactivation. In a complementary investigation Tsujimoto et al. [10] found that the skeleton and the substituents of flavonoids were important for their inhibitory effects on CYP3A activity in human liver microsomes.
Based on the information available and according to our results, it is of further interest whether cytoprotective effects of 1 and 3 are also due to interactions at the metabolic level between CCl 4 and 1 and 3. Interestingly, in vitro cytotoxic effects only occur at more than 10fold higher concentrations in HepG2 cells making flavonoid glycosides with a 6-methoxykaempferol skeleton a promising and safe class of hepatoprotective compounds. 
6-Methoxykaempferol 3-O-[β-D-apiofuranosyl(1→2)]-β-Dglucopyranosyl(1→6)-β-D-glucopyranoside
: +20.0 (c 0.10, MeOH Acid hydrolysis of 2: Compound 2 (4 mg) was refluxed with 2 mL of 2N HCl-MeOH (1:1) for 2 h. The reaction mixture was filtered through Diaion HP-20SS followed by subsequent elution with H 2 O and MeOH. The water portion was filtered through Amberlite IRC-86 resin and then evaporated to dryness. The absolute configuration of the sugars was established using the method of Tanaka et al. with some modifications [7] . Briefly, the dry water eluate was treated with a solution (0.1 mL) of L-cysteine methyl ester in pyridine (5 mg/mL) at 60°C for 1 h. A solution (0.1 mL) of otolylisothiocyanate in pyridine (5 mg/mL) was added to the mixture and heated at 60°C for 1 h. The resulting solution was analyzed using HPLC [Purospher STAR RP-18 5 µm column (Merck; 4.6×250 mm) with 25% ACN in 50 mM H 3 PO 4 , flow rate 1 mL/min, UV detection at 250 nm]. The presence of D-glucose and D-apiose (t R values of the tolylthiocarbamoyl-thiazolidine derivatives were 18.7 and 32.2 min) was found in the residue.
Antioxidant tests:
Compounds 1 and 3 were tested for anti-oxidant activity using the following methods: DPPH [11] and ABTS [12] radical scavenging activity, ferric reducing/anti-oxidant power (FRAP) [13] and determination of anti-oxidant activity in a linoleic acid system by the FTC method [14] .
Animal experiments: Male Wistar rats (body weight, 200-250 g) were used. Rats were housed in plexiglass cages (3 per cages) in a 12/12 light/dark cycle, temperature 20 ± 2°C. Food and water were provided ad libitum. Animals were purchased from the National Breeding Centre, Sofia, Bulgaria. All experiments were performed after at least one week of adaptation to this environment. The experimental procedures were approved by the Institutional Animal Care and Use Committee at the Medical University-Sofia, Bulgaria. The principles stated in the European Convention for the Protection of Vertebrate Animals used for Experimental and other Scientific
